v3.26.1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 2,285 $ 7,323
Cost of revenue 1,769 5,788
Gross profit 516 1,535
Operating expenses:    
Research and development 1,223 1,293
General and administrative 2,834 2,673
Sales and marketing 207 443
Foreign exchange loss (gain) 1,007 (1,203)
Depreciation and amortization 110 107
Operating expenses 5,381 3,313
Loss from continuing operations (4,865) (1,778)
Loss from investments accounted for by the equity method (note 8) (1,381) (3,884)
Interest on long-term debt (90) (192)
Interest and other income, net of bank charges 742 649
Loss before income taxes (5,594) (5,205)
Income tax expense 113 90
Net loss from continuing operations (5,707) (5,295)
Net income from discontinued operations (note 5) 0 2,844
Net loss for the period (5,707) (2,451)
Other comprehensive income (loss):    
Cumulative translation adjustment 1,874 3,641
Ownership share of equity method investments' other comprehensive loss (2,182) (829)
Other comprehensive income (loss) (308) 2,812
Comprehensive (loss) income $ (6,015) $ 361
Net income (loss) per share:    
From continuing operations - basic (in dollars per share) $ (0.33) $ (0.31)
From discontinued operations - basic (in dollars per share) 0 0.16
From continuing operations - diluted (in dollars per share) (0.33) (0.31)
From discontinued operations - diluted (in dollars per share) 0 0.16
Net loss per share - basic (in dollars per share) (0.33) (0.14)
Net loss per share - diluted (in dollars per share) $ (0.33) $ (0.14)
Weighted average common shares outstanding:    
Basic (in shares) 17,394,594 17,322,681
Diluted (in shares) 17,394,594 17,322,681